AI assistant
Sending…
Imunon, Inc. — Director's Dealing 2011
Mar 1, 2011
35124_dirs_2011-03-01_717ab6e2-08a6-4b54-b5da-2276cbad23e6.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Celsion CORP (CLSN)
CIK: 0000749647
Period of Report: 2011-02-25
Reporting Person: LINK MAX (Director)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2011-02-25 | Option to purchase common stock | $2.49 | A | 50000 | Acquired | 2021-02-25 | Celsion Corporation Common Stock (50000) | Direct |
Footnotes
F1: Options to purchase shares of Celsion Corporation Common Stock vest in thirds over three years, with the first vesting date on February 25, 2012 and annually thereafter.
F2: Closing price of Celsion Corporation Common Stock on date of award.
More from Imunon, Inc.
Capital/Financing Update
2026
Jun 4
Interim / Quarterly Report
2026
May 12
Regulatory Filings
2026
May 12
Annual Report
2026
May 4
Regulatory Filings
2026
May 4
Proxy Solicitation & Information Statement
2026
May 4
Annual Report
2026
Mar 31
Regulatory Filings
2026
Mar 31
Capital/Financing Update
2026
Mar 23
Regulatory Filings
2026
Mar 23